MaxCyte, Inc. (MXCT) Operating income 2019–2025
MaxCyte, Inc. (MXCT) annual operating income history from SEC filings — each fiscal year as reported.
-$51.9MFY2025 · since FY2019: -$12.4M → -$51.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.9M | -1.4% |
| FY2024 | -$51.2M | -6.0% |
| FY2023 | -$48.3M | -76.5% |
| FY2022 | -$27.4M | -50.4% |
| FY2021 | -$18.2M | -64.5% |
| FY2020 | -$11.1M | +11.0% |
| FY2019 | -$12.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MXCT financial trends
MXCT RevenueMXCT Net incomeMXCT Net marginMXCT Gross profitMXCT Gross marginMXCT Operating marginMXCT Operating cash flowMXCT Free cash flowMXCT Capital expendituresMXCT Return on equityMXCT Stock buybacksMXCT Dividends paidMXCT Total assetsMXCT Total liabilitiesMXCT Shareholders’ equityMXCT overview →